Anal Fissure ChronicPhase 1RCTNCT06633185
Effect of Phenytoin Cream on Wound Healing After Anal Fissure Surgery.
A Phase 1 study testing phenytoin cream and no phenytoin cream in people with Anal Fissure Chronic and Anal Fissure, run by Mansoura University at 1 site in Egypt.
Trial summary
This study aims to compare the effect of phenytoin cream on wound healing after anal fissure surgery compared to control group. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Anal Fissure Chronic, Anal Fissure, Wound Healing
- What is being tested?
- phenytoin cream and no phenytoin cream
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2022to 1 Jan 2023
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients of both sexes,
- Aged between 18 and 65 years old,
- with chronic anal fissure after failure of previous conservative treatment.
Who cannot join
- surgically unfit patients due to multiple comorbidities,
- patients with concomitant other anorectal pathology,
- patient with anal fissure secondary to inflammatory bowel disease,
- patients with active anorectal sepsis
- patients with previous anal surgery .
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Phenytoin Cream on Wound Healing After Anal Fissure Surgery; a Randomized Controlled Trail.
This study aims to compare the effect of phenytoin cream on wound healing after anal fissure surgery compared to control group.
Read the detailed description
Introduction Anal fissure is defined as an elliptical or longitudinal tear in the anoderm distal to the dentate line, exactly proximal to or at the level of the anal verge . It is one of the most painful anal disorders that inversely affect the life quality of the patients .
Acute anal fissure is a simple rupture in the anoderm existing for less than two months and it is associated with anal pain, spasm, and/or bleeding with defecation. Chronic anal fissure is present for more than six weeks and it is characterized by exposed fibers of internal anal sphincters at the base, hypertrophied anal papilla proximally, and a skin tag or sentinel pile .
Conservative methods are likely to fail and have a higher failure rate with chronically recurring anal fissures. In these situations, the gold standard is the internal sphincterotomy. This surgical procedure treats chronic fissure by preventing hypertonia of the internal sphincter .
Wound healing is an essential step during the procedure of post-operative care after anal surgery . For example, it is believed that a desirable wound healing could help reduce the post-operative pain after hemorrhoidectomy, which quite commonly causes delayed patient discharge .
However, due to the unusual circumstance, the wound healing after anal surgery is frequently delayed by postoperative complications, such as bleeding, infection and edema, despite the use of wound healing creams . Therefore, it is still necessary to investigate more efficient therapeutic regimen to accelerate the postoperative wound healing after anal surgery.
Phenytoin is an anticonvulsant non-sedative agent, studied as a topical cream in skin lacerations, diabetic foot, pressure ulcer, and leprosy as well as oral and dental injuries . Its efficacy has been approved in all of the previous fields . This agent could activate fibroblastic proliferation, attenuate collagenase activity, inhibit glucocorticoid production, increase granulation tissue, activate angiogenesis and decrease microbial infection for accelerating wound repair .
Aim of the Work The current study will be conducted to evaluate the effect of topical phenytoin cream application on the healing process of the anal wound, following sphincterotomy for chronic anal fissure.
Patients and Methods Study design This is a prospective randomized controlled trial that will be conducted at the colorectal surgery unit of the general surgery department, at Mansoura university hospitals between January 2022 and January 2023.
Eligibility criteria Patients of both sexes, who aged between 18 and 65 years old, with chronic anal fissure after failure of previous conservative treatment including dietary modifications, laxatives, and topical therapy will be included in this study. Whereas, surgically unfit patients due to multiple comorbidities, patients with concomitant other anorectal pathology, patient with anal fissure secondary to inflammatory bowel disease, patients with active anorectal sepsis and patients with previous anal surgery will be excluded.
Random sequence generation and blinding Patients will be randomized to one of two equal groups; group I (treatment group) will be treated with lateral internal sphincterotomy with topical application of phenytoin 2% (Heal Quick®, Al hadidi pharm, Egypt), and group II (control group) will be treated with lateral internal sphincterotomy alone.
Randomization will be undertaken by the sealed envelope method using randomization software (www.randomization.com). The operating surgeon will not be aware to the nature of the study.
Preoperative assessment Detailed history will be taken from the patients with regard to complaint and its duration, associated medical conditions, previous surgical operations, previous treatments for the current condition, presence of anal pain, constipation and fecal continence state. Thorough clinical examination will be done for all patients. Local anorectal examination will be performed by direct inspection and digital rectal examination, to confirm presence of anal fissure and to exclude associated anorectal lesions. The diagnosis with chronic anal fissure was established when the patient report persistence of his symptoms for more than six weeks, along with the presence of a fissure showing the signs of chronicity (indurated edges, visible internal sphincter fibers through the base of the fissure, hypertrophic anal papilla, and sentinel pile) [14].Routine laboratory investigations including complete blood count, liver and kidney function tests, prothrombin time, and random blood glucose level will be conducted.
Operative technique:
All patients will be provided with an informed consent regarding the procedure and its complications. All patients will be placed in lithotomy position after receiving spinal anesthesia. Lateral internal sphincterotomy will be performed for all cases. The anal mucosa will be grasped using a pair of forceps, and after excision of the skin tag, the internal sphincter will be identified and separated from anal mucosa using a dissecting scissor, then a tailored internal anal sphincterotomy will be performed at 5 o'clock position by dividing the internal sphincter fibers using diathermy. After that, the wound will be left open for drainage. Proper hemostasis will be asserted then pressure dressing will be placed on the anal verge for 12 hours.
Post-operative:
Patients will be monitored in the regular ward by vital signs assessment and observation of the anal wound. Patients will be instructed to do frequent Sitz bath every six hours. During the postoperative period all patients will receive a single dose of intravenous cephalosporins and then followed by oral quinolones tablets and Non-steroidal anti-inflammatory drug (NSAIDS) for one week. For group I, additional topical phenytoin cream 2% will be commenced. It will be administered topically over wound, twice daily for one month after operation. All patients will be discharged home in the 1st postoperative day as long as there are no complications.
End points and follow up
All patients will be followed up at the outpatient clinic, every week for 1 month and the following outcomes will be assessed between both groups:
- The primary endpoint will be the duration of healing of anal fissure. It will be defined as complete epithelization of the anal wound. Whereas, the secondary outcome will be the post-operative complications.
- Post-operative pain according to the visual analogue scale (VAS)[15].
- Postoperative analgesic requirements including whether the patient required additional opioids.
- Immediate post-operative complications e.g anal bleeding or urine retention.
- Time taken to return to daily activities in days.
- Time taken for the patient to defecate without pain.
- Conditions
- Anal Fissure Chronic, Anal Fissure, Wound Healing
- Being tested
- phenytoin cream, no phenytoin cream
- Medical subject headings
- Fissure in Ano
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
phenytoin creamDrug
Also called heal quick, phenytoin
application of the cream after internal anal sphincterotomy versus non application.
no phenytoin creamDrug
Also called heal quick
Non application of the phenytoin cream
| Study group | Role | What they receive |
|---|---|---|
| Topical anal phenytoin cream application | Active comparator | local application of phenytoin cream on anal wound post internal sphincterotomy for chronic anal fissure. Receives: Drug: phenytoin cream |
| control arm | Active comparator | includes those with internal sphincterotomy but without application of topical phenytoin cream Receives: Drug: no phenytoin cream |
What is being measured
The primary outcome is the main question the study is designed to answer.
The duration of healing of anal fissure.
The primary endpoint will be the duration of healing of anal fissure in days. It will be defined as complete epithelization of the anal wound.
Measured: 21 to 30 days
Secondary outcomes (1)
post operative complications and others
Postoperative analgesic requirements including whether the patient required additional opioids. It is measured by number of analgesic injections needed.
Immediate post-operative complications e.g anal bleeding or urine retention. It is measured by number of cases which developed these complications Time taken to return to daily activities in days. Time taken for the patient to defecate without pain in days .
Measured: 14 to 21 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2024
- Study start1 Jan 2022
- Primary completion1 Aug 2022
- Study completion1 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anal Fissure ChronicStudies of the same condition, open and under way.
- More trials run by Mansoura UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- 1st arm includes those patients who underwent application of topical phenytoin cream after anal fissure surgery, while the other arm includes those without application of any creams( control).
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmad Sakr, Mansoura University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06633185
- Sponsor's protocol ID
- 223345
- Acronym
- RCT
- Status last verified
- Sep 2024
- First submitted
- 4 Oct 2024
- Last updated
- 9 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Phenytoin Cream on Wound Healing After Anal Fissure Surgery; a Randomized Controlled Trail.
- ClinicalTrials.gov ID
- NCT06633185
- Acronym / sponsor ID
- RCT / 223345
- Conditions
- Anal Fissure Chronic, Anal Fissure, Wound Healing
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Mansoura UniversityUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 1 Aug 2022 (actual)
- Study completion
- 1 Jan 2023 (actual)
- First posted
- 9 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare the effect of phenytoin cream on wound healing after anal fissure surgery compared to control group.
Detailed description
Introduction Anal fissure is defined as an elliptical or longitudinal tear in the anoderm distal to the dentate line, exactly proximal to or at the level of the anal verge . It is one of the most painful anal disorders that inversely affect the life quality of the patients .
Acute anal fissure is a simple rupture in the anoderm existing for less than two months and it is associated with anal pain, spasm, and/or bleeding with defecation. Chronic anal fissure is present for more than six weeks and it is characterized by exposed fibers of internal anal sphincters at the base, hypertrophied anal papilla proximally, and a skin tag or sentinel pile .
Conservative methods are likely to fail and have a higher failure rate with chronically recurring anal fissures. In these situations, the gold standard is the internal sphincterotomy. This surgical procedure treats chronic fissure by preventing hypertonia of the internal sphincter .
Wound healing is an essential step during the procedure of post-operative care after anal surgery . For example, it is believed that a desirable wound healing could help reduce the post-operative pain after hemorrhoidectomy, which quite commonly causes delayed patient discharge .
However, due to the unusual circumstance, the wound healing after anal surgery is frequently delayed by postoperative complications, such as bleeding, infection and edema, despite the use of wound healing creams . Therefore, it is still necessary to investigate more efficient therapeutic regimen to accelerate the postoperative wound healing after anal surgery.
Phenytoin is an anticonvulsant non-sedative agent, studied as a topical cream in skin lacerations, diabetic foot, pressure ulcer, and leprosy as well as oral and dental injuries . Its efficacy has been approved in all of the previous fields . This agent could activate fibroblastic proliferation, attenuate collagenase activity, inhibit glucocorticoid production, increase granulation tissue, activate angiogenesis and decrease microbial infection for accelerating wound repair .
Aim of the Work The current study will be conducted to evaluate the effect of topical phenytoin cream application on the healing process of the anal wound, following sphincterotomy for chronic anal fissure.
Patients and Methods Study design This is a prospective randomized controlled trial that will be conducted at the colorectal surgery unit of the general surgery department, at Mansoura university hospitals between January 2022 and January 2023.
Eligibility criteria Patients of both sexes, who aged between 18 and 65 years old, with chronic anal fissure after failure of previous conservative treatment including dietary modifications, laxatives, and topical therapy will be included in this study. Whereas, surgically unfit patients due to multiple comorbidities, patients with concomitant other anorectal pathology, patient with anal fissure secondary to inflammatory bowel disease, patients with active anorectal sepsis and patients with previous anal surgery will be excluded.
Random sequence generation and blinding Patients will be randomized to one of two equal groups; group I (treatment group) will be treated with lateral internal sphincterotomy with topical application of phenytoin 2% (Heal Quick®, Al hadidi pharm, Egypt), and group II (control group) will be treated with lateral internal sphincterotomy alone.
Randomization will be undertaken by the sealed envelope method using randomization software (www.randomization.com). The operating surgeon will not be aware to the nature of the study.
Preoperative assessment Detailed history will be taken from the patients with regard to complaint and its duration, associated medical conditions, previous surgical operations, previous treatments for the current condition, presence of anal pain, constipation and fecal continence state. Thorough clinical examination will be done for all patients. Local anorectal examination will be performed by direct inspection and digital rectal examination, to confirm presence of anal fissure and to exclude associated anorectal lesions. The diagnosis with chronic anal fissure was established when the patient report persistence of his symptoms for more than six weeks, along with the presence of a fissure showing the signs of chronicity (indurated edges, visible internal sphincter fibers through the base of the fissure, hypertrophic anal papilla, and sentinel pile) [14].Routine laboratory investigations including complete blood count, liver and kidney function tests, prothrombin time, and random blood glucose level will be conducted.
Operative technique:
All patients will be provided with an informed consent regarding the procedure and its complications. All patients will be placed in lithotomy position after receiving spinal anesthesia. Lateral internal sphincterotomy will be performed for all cases. The anal mucosa will be grasped using a pair of forceps, and after excision of the skin tag, the internal sphincter will be identified and separated from anal mucosa using a dissecting scissor, then a tailored internal anal sphincterotomy will be performed at 5 o'clock position by dividing the internal sphincter fibers using diathermy. After that, the wound will be left open for drainage. Proper hemostasis will be asserted then pressure dressing will be placed on the anal verge for 12 hours.
Post-operative:
Patients will be monitored in the regular ward by vital signs assessment and observation of the anal wound. Patients will be instructed to do frequent Sitz bath every six hours. During the postoperative period all patients will receive a single dose of intravenous cephalosporins and then followed by oral quinolones tablets and Non-steroidal anti-inflammatory drug (NSAIDS) for one week. For group I, additional topical phenytoin cream 2% will be commenced. It will be administered topically over wound, twice daily for one month after operation. All patients will be discharged home in the 1st postoperative day as long as there are no complications.
End points and follow up
All patients will be followed up at the outpatient clinic, every week for 1 month and the following outcomes will be assessed between both groups:
- The primary endpoint will be the duration of healing of anal fissure. It will be defined as complete epithelization of the anal wound. Whereas, the secondary outcome will be the post-operative complications.
- Post-operative pain according to the visual analogue scale (VAS)[15].
- Postoperative analgesic requirements including whether the patient required additional opioids.
- Immediate post-operative complications e.g anal bleeding or urine retention.
- Time taken to return to daily activities in days.
- Time taken for the patient to defecate without pain.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- 1st arm includes those patients who underwent application of topical phenytoin cream after anal fissure surgery, while the other arm includes those without application of any creams( control).
| Arm | Type | Receives |
|---|---|---|
| Topical anal phenytoin cream application | Active comparator | Drug: phenytoin creamlocal application of phenytoin cream on anal wound post internal sphincterotomy for chronic anal fissure. |
| control arm | Active comparator | Drug: no phenytoin creamincludes those with internal sphincterotomy but without application of topical phenytoin cream |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients of both sexes,
- Aged between 18 and 65 years old,
- with chronic anal fissure after failure of previous conservative treatment.
Key exclusion criteria (5 listed)
- surgically unfit patients due to multiple comorbidities,
- patients with concomitant other anorectal pathology,
- patient with anal fissure secondary to inflammatory bowel disease,
- patients with active anorectal sepsis
- patients with previous anal surgery .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| phenytoin creamAlso: heal quick, phenytoinapplication of the cream after internal anal sphincterotomy versus non application. | Drug | Topical anal phenytoin cream application |
| no phenytoin creamAlso: heal quickNon application of the phenytoin cream | Drug | control arm |
Primary outcome
The duration of healing of anal fissure.
Time frame: 21 to 30 days
The primary endpoint will be the duration of healing of anal fissure in days. It will be defined as complete epithelization of the anal wound.
1 secondary outcome
post operative complications and others
Time frame: 14 to 21 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Anal Fissure Chronic
RecruitingObservational study
Ultrasound Assessment After Surgery for Chronic Anal Fissure
Anal Fissure Chronic
Not yet recruitingPhase 4
Emerging Indications for Hyperbaric Oxygen Treatment
Post-COVID-19 Condition, Ulcerative Colitis
Recruiting
AI-Assisted Written Information in Chronic Anal Fissure
Chronic Anal Fissure
Recruiting
Comparative Outcomes of Inj Botox Alone vs Inj Botox Combined With Fissurectomy and Anoplasty in the Management of Chronic Anal Fissure
Anal Fissure Chronic
Not yet recruitingObservational study
Female Sexual Function After Surgery for Benign Perianal Diseases
Chronic Anal Fissure, Hemorrhoidal Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing phenytoin cream and no phenytoin cream in people with Anal Fissure Chronic and Anal Fissure, run by Mansoura University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The duration of healing of anal fissure. (time frame: 21 to 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2024.